Implandata Ophthalmic Products GmbH (IOP) is an early stage, privately-held, venture capital funded medical device company based in Hannover, Germany.
IOP has developed a novel technology for 24 hour measurement of intraocular pressure, by which monitoring and therapy of glaucoma patients will be improved. This solution will allow a more efficient treatment and management of glaucoma patients.
Funding Rounds (4) - $8.52MUpdate
Board Members and Advisors (1)Update
|Oct 27, 2014||b3cnewswire.com - Implandata Announces Closing of €3M Series B-Round, Establishment of Fully Owned USA Subsidiary and Progress in Clinical Program|
|Aug 30, 2012||FinSMEs - Implandata Ophthalmic Products raises 2007040 in venture round|
|Jan 31, 2012||FinSMEs - Implandata Ophthalmic Products raises 1844640 in venture round|
Vahrenwalder Strasse 7
Hanover, Niedersachsen 30165